{"hands_on_practices": [{"introduction": "To truly understand antibiotic resistance, we must look beyond memorizing gene names and delve into the physical principles that govern a drug's journey into a bacterial cell. This first practice invites you to build a quantitative model from the ground up, using Fick's first law of diffusion to explore how the loss of porin channels—the cell's molecular gateways—profoundly impacts the concentration of antibiotic required to be effective. By deriving and applying this model, you will gain a concrete appreciation for how a simple structural change can confer a powerful survival advantage to pathogens like *Klebsiella pneumoniae* [@problem_id:4643156].", "problem": "Consider a population of Klebsiella pneumoniae (K. pneumoniae) cells exposed to a constant extracellular concentration of a hydrophilic antibiotic that enters the periplasm and cytoplasm predominantly through outer membrane porin channels. Assume each porin functions as an identical, non-interacting cylindrical diffusion conduit of effective length $L$ and cross-sectional area $A_{p}$. Let the antibiotic’s diffusion coefficient within the porin be $D$. The cell’s cytoplasmic volume is $V$. The intracellular antibiotic is cleared by lumped first-order processes (e.g., active efflux, metabolism, binding and sequestration) with rate constant $k$, assumed to act homogeneously in the cytoplasm.\n\nUse Fick’s first law of diffusion as the fundamental base, where the steady-state diffusive flux through a single channel is given by $J_{\\text{single}} = D A_{p} \\frac{C_{o} - C_{i}}{L}$, with $C_{o}$ the extracellular concentration and $C_{i}$ the cytoplasmic concentration. Channels act in parallel, so the total influx scales with the number of open, conductance-competent porins $N$. At steady state, intracellular concentration is maintained when the net influx equals the net first-order clearance. Starting from these principles, derive an expression for the extracellular concentration $C_{o}^{\\star}$ required to sustain a specified target intracellular concentration $C_{i}^{\\star}$ at steady state, as a function of $N$, $D$, $A_{p}$, $L$, $V$, and $k$. Then, using this expression, compute the fold-increase in $C_{o}^{\\star}$ when the number of effective porin channels is reduced from $N_{\\text{high}} = 800$ to $N_{\\text{low}} = 50$.\n\nUse the following parameter values, which are representative for a large, hydrophilic cephalosporin crossing narrow porins in gram-negative bacteria:\n- $D = 1.0 \\times 10^{-11} \\,\\text{m}^{2}\\,\\text{s}^{-1}$,\n- $A_{p} = 1.0 \\times 10^{-18} \\,\\text{m}^{2}$,\n- $L = 6.0 \\times 10^{-9} \\,\\text{m}$,\n- $V = 1.2 \\times 10^{-18} \\,\\text{m}^{3}$,\n- $k = 0.80 \\,\\text{s}^{-1}$,\n- $C_{i}^{\\star} = 2.0 \\times 10^{-6} \\,\\text{mol}\\,\\text{m}^{-3}$.\n\nExpress your final answer as a unitless fold change $F = \\frac{C_{o}^{\\star}(N_{\\text{low}})}{C_{o}^{\\star}(N_{\\text{high}})}$. Round your final answer to three significant figures.", "solution": "The problem asks for the derivation of the extracellular antibiotic concentration $C_{o}^{\\star}$ required to maintain a target intracellular concentration $C_{i}^{\\star}$ at steady state, and subsequently to calculate the fold-increase in $C_{o}^{\\star}$ when the number of porin channels, $N$, is reduced.\n\nThe solution proceeds in two main steps:\n1.  Derivation of the expression for $C_{o}^{\\star}$ based on the steady-state condition.\n2.  Calculation of the fold-increase $F = \\frac{C_{o}^{\\star}(N_{\\text{low}})}{C_{o}^{\\star}(N_{\\text{high}})}$ using the derived expression and given parameters.\n\nFirst, we establish the mathematical model for antibiotic concentration dynamics within a single bacterial cell. The change in the amount of intracellular antibiotic over time is determined by the balance between influx and clearance.\n\nThe influx of the antibiotic occurs via diffusion through $N$ identical porin channels. The rate of influx of moles of the antibiotic through a single channel is given by Fick's first law, as stated in the problem:\n$$J_{\\text{single}} = D A_{p} \\frac{C_{o} - C_{i}}{L}$$\nHere, $J_{\\text{single}}$ represents the molar flow rate (moles per unit time). Since the $N$ channels act in parallel and are non-interacting, the total molar influx rate, $J_{\\text{influx}}$, is the sum of the individual rates:\n$$J_{\\text{influx}} = N \\cdot J_{\\text{single}} = N D A_{p} \\frac{C_{o} - C_{i}}{L}$$\n\nThe clearance of the antibiotic from the cytoplasm is modeled as a lumped first-order process with a rate constant $k$. This process acts on the total amount of antibiotic present in the cytoplasm. The amount of antibiotic (in moles) within the cytoplasmic volume $V$ is given by $n_{i} = C_{i} V$. The rate of a first-order process is proportional to the amount of substance, so the total molar clearance rate, $J_{\\text{clearance}}$, is:\n$$J_{\\text{clearance}} = k \\cdot n_{i} = k C_{i} V$$\n\nAt steady state, the intracellular concentration $C_{i}$ is constant. This occurs when the rate of influx equals the rate of clearance:\n$$J_{\\text{influx}} = J_{\\text{clearance}}$$\nSubstituting the expressions for influx and clearance, we get the steady-state equation:\n$$N D A_{p} \\frac{C_{o} - C_{i}}{L} = k C_{i} V$$\n\nThe problem requires us to find the external concentration, $C_{o}^{\\star}$, needed to maintain a specific target internal concentration, $C_{i}^{\\star}$. We achieve this by rearranging the steady-state equation to solve for $C_{o}$ and then substituting $C_{i}$ with $C_{i}^{\\star}$ and $C_{o}$ with $C_{o}^{\\star}$.\n\nLet's solve for $C_{o}$:\n$$N D A_{p} (C_{o} - C_{i}) = L k C_{i} V$$\n$$C_{o} - C_{i} = \\frac{L k V}{N D A_{p}} C_{i}$$\n$$C_{o} = C_{i} + \\frac{L k V}{N D A_{p}} C_{i}$$\nFactoring out $C_{i}$, we obtain the general expression for $C_{o}$ as a function of $C_{i}$ and other parameters:\n$$C_{o} = C_{i} \\left( 1 + \\frac{L k V}{N D A_{p}} \\right)$$\nFor a target intracellular concentration $C_{i}^{\\star}$, the required extracellular concentration $C_{o}^{\\star}$ is therefore:\n$$C_{o}^{\\star}(N) = C_{i}^{\\star} \\left( 1 + \\frac{L k V}{N D A_{p}} \\right)$$\nThis is the derived expression for $C_{o}^{\\star}$ as a function of the system parameters, including the number of porins $N$.\n\nNext, we are asked to compute the fold-increase in $C_{o}^{\\star}$ when the number of effective porin channels is reduced from $N_{\\text{high}} = 800$ to $N_{\\text{low}} = 50$. The fold-increase $F$ is the ratio:\n$$F = \\frac{C_{o}^{\\star}(N_{\\text{low}})}{C_{o}^{\\star}(N_{\\text{high}})}$$\nUsing our derived expression for $C_{o}^{\\star}(N)$:\n$$F = \\frac{C_{i}^{\\star} \\left( 1 + \\frac{L k V}{N_{\\text{low}} D A_{p}} \\right)}{C_{i}^{\\star} \\left( 1 + \\frac{L k V}{N_{\\text{high}} D A_{p}} \\right)}$$\nThe term $C_{i}^{\\star}$ cancels out:\n$$F = \\frac{1 + \\frac{L k V}{N_{\\text{low}} D A_{p}}}{1 + \\frac{L k V}{N_{\\text{high}} D A_{p}}}$$\nTo proceed with the numerical calculation, we first compute the dimensionless group of constants, let's call it $\\beta = \\frac{L k V}{D A_{p}}$.\nUsing the provided values:\n$L = 6.0 \\times 10^{-9} \\,\\text{m}$\n$k = 0.80 \\,\\text{s}^{-1}$\n$V = 1.2 \\times 10^{-18} \\,\\text{m}^{3}$\n$D = 1.0 \\times 10^{-11} \\,\\text{m}^{2}\\,\\text{s}^{-1}$\n$A_{p} = 1.0 \\times 10^{-18} \\,\\text{m}^{2}$\n\n$$\\beta = \\frac{(6.0 \\times 10^{-9} \\,\\text{m}) (0.80 \\,\\text{s}^{-1}) (1.2 \\times 10^{-18} \\,\\text{m}^{3})}{(1.0 \\times 10^{-11} \\,\\text{m}^{2}\\,\\text{s}^{-1}) (1.0 \\times 10^{-18} \\,\\text{m}^{2})}$$\n$$\\beta = \\frac{(6.0 \\cdot 0.80 \\cdot 1.2) \\times 10^{-9-18}}{(1.0 \\cdot 1.0) \\times 10^{-11-18}} = \\frac{5.76 \\times 10^{-27}}{1.0 \\times 10^{-29}} = 576$$\nThe term $\\beta$ is a dimensionless constant. Now we can write the expression for $F$ as:\n$$F = \\frac{1 + \\frac{\\beta}{N_{\\text{low}}}}{1 + \\frac{\\beta}{N_{\\text{high}}}}$$\nSubstituting the values $N_{\\text{low}} = 50$, $N_{\\text{high}} = 800$, and $\\beta = 576$:\n$$F = \\frac{1 + \\frac{576}{50}}{1 + \\frac{576}{800}}$$\n$$F = \\frac{1 + 11.52}{1 + 0.72} = \\frac{12.52}{1.72}$$\n$$F \\approx 7.2790697...$$\nThe problem requires the final answer to be rounded to three significant figures.\n$$F \\approx 7.28$$\nThis result indicates that a more than $7$-fold increase in the external antibiotic concentration is necessary to overcome the reduction in porin channels and maintain the same target intracellular concentration. This highlights porin loss as a potent mechanism of antibiotic resistance.", "answer": "$$\\boxed{7.28}$$", "id": "4643156"}, {"introduction": "While single-cell mechanisms are crucial, the true challenge of *K. pneumoniae* often lies in its ability to form complex communities called biofilms. This practice moves from the individual to the collective, presenting you with a realistic clinical scenario of a biofilm infection. Your task is to act as a scientific investigator, using provided experimental data to dissect the multiple, synergistic mechanisms—from diffusion barriers to metabolic slowdowns—that make these bacterial fortresses so resilient against antibiotics [@problem_id:4643195].", "problem": "A hospitalized patient with a long-term urinary catheter develops a catheter-associated urinary tract infection caused by Klebsiella pneumoniae. Microscopy shows a mature biofilm with a thickness of approximately $50\\,\\mu\\text{m}$ composed of bacteria embedded in an extracellular polymeric substance (EPS) matrix. The clinical team administers a $\\beta$-lactam antibiotic at a bulk concentration $C_0$ equal to $10\\times$ the minimum inhibitory concentration (MIC) for planktonic Klebsiella pneumoniae. Confocal imaging with a fluorescent analog reveals that, even after $60$ minutes, fluorescence intensity (a proxy for local antibiotic concentration) in deeper layers is significantly lower than at the biofilm surface, and oxygen microelectrodes detect an anoxic zone beyond $30\\,\\mu\\text{m}$ from the biofilm surface. After exposure, killing curves are biphasic, with a rapid initial decline followed by a plateau indicating a small surviving fraction that later repopulates once the antibiotic is removed.\n\nUse the following foundational bases to reason mechanistically: (i) transport into a biofilm requires diffusion driven by concentration gradients and can be impeded by reduced effective diffusivity and reversible binding, (ii) antibiotics must reach their cellular targets at or above inhibitory concentrations to exert effects, and (iii) many antibiotic mechanisms depend on active cellular processes and growth. Klebsiella pneumoniae is known to produce a polysaccharide capsule and, in some strains, extended-spectrum $\\beta$-lactamases (ESBL).\n\nWhich of the following mechanistic explanations best account for the increased antibiotic tolerance of Klebsiella pneumoniae biofilms under these conditions? Select all that apply.\n\nA. The EPS matrix reduces the effective diffusion coefficient $D_{\\text{eff}}$ relative to free solution and can sequester certain antibiotics, creating a spatial concentration profile $C(x)$ where deeper layers do not attain $C(x)\\ge\\text{MIC}$. Additionally, $\\beta$-lactamases produced by Klebsiella pneumoniae concentrated within the matrix locally degrade $\\beta$-lactams, steepening the decline of $C(x)$ with depth.\n\nB. Nutrient and oxygen gradients drive interior cells into slow-growth or stationary states with low specific growth rate $\\mu\\approx 0$, reduced proton motive force, and downregulated target activity; antibiotics that require active processes (for example, $\\beta$-lactams for cell wall synthesis or aminoglycosides for energy-dependent uptake) are thus less effective in these zones.\n\nC. A subpopulation of persister cells enters a transient dormant phenotype without heritable genetic change. These cells survive high antibiotic exposure and repopulate once the drug is removed, explaining the biphasic killing curves and non-heritable tolerance observed in biofilms.\n\nD. Horizontal gene transfer within biofilms rapidly fixes chromosomal resistance mutations across the entire population during a single treatment course, making stable genetic resistance the primary cause of the observed tolerance in this scenario.\n\nE. Uniform, high-level overexpression of efflux pumps by all biofilm cells fully accounts for the observed tolerance, rendering diffusion limitations, metabolic state changes, and persister formation unnecessary to explain the data.", "solution": "The problem statement is scientifically sound, internally consistent, and well-posed. It describes a classic, realistic scenario of antibiotic tolerance in a bacterial biofilm and provides sufficient data and guiding principles to evaluate the proposed mechanisms. All terms are clearly defined, and the observations are standard findings in the field of medical microbiology.\n\nThe increased antibiotic tolerance of the *Klebsiella pneumoniae* biofilm is a multifactorial phenomenon. We will analyze the contribution of each proposed mechanism in light of the provided observations and foundational principles.\n\n**Analysis of Observations and Principles:**\n\n1.  **Transport Limitation and Reaction-Diffusion:** The problem states that after $60$ minutes, the antibiotic concentration is significantly lower in deeper layers. This is a direct observation of a steep concentration gradient, $C(x)$, where $x$ is the depth into the biofilm. Foundational Principle (i) states that transport into a biofilm is governed by diffusion, which can be impeded. The extracellular polymeric substance (EPS) matrix creates a tortuous path for diffusing molecules, reducing the effective diffusion coefficient, $D_{\\text{eff}}$, compared to its value in water. Furthermore, the problem states the antibiotic is a $\\beta$-lactam and that *K. pneumoniae* can produce $\\beta$-lactamases (ESBLs). These enzymes, concentrated within the biofilm matrix, act as a sink for the antibiotic, degrading it as it diffuses. This introduces a reaction term into the mass transport equation. The steady-state concentration profile is described by a reaction-diffusion equation, which in one dimension is $D_{\\text{eff}} \\frac{d^2 C}{dx^2} = R(C)$, where $R(C)$ is the rate of antibiotic consumption (e.g., enzymatic degradation). The combined effects of reduced $D_{\\text{eff}}$ and a non-zero $R(C)$ can cause the concentration $C(x)$ to fall below the minimum inhibitory concentration (MIC) in a significant portion of the biofilm, specifically in the deeper layers. This directly explains why cells in these layers survive, as per Foundational Principle (ii).\n\n2.  **Metabolic Heterogeneity and Growth-Rate-Dependent Efficacy:** The detection of an anoxic zone beyond $30\\,\\mu\\text{m}$ is direct evidence of metabolic stratification. Bacteria near the surface (the outer $0-30\\,\\mu\\text{m}$) consume oxygen and other nutrients, creating gradients. Cells in the deeper, anoxic layers are forced into slow-growth or stationary metabolic states, characterized by a low specific growth rate ($\\mu \\approx 0$). Foundational Principle (iii) states that many antibiotics depend on active cellular processes. $\\beta$-lactam antibiotics, used in this scenario, function by inhibiting transpeptidases involved in peptidoglycan synthesis, a crucial part of cell wall construction during active growth and division. In non-growing or slow-growing cells, the rate of peptidoglycan synthesis is very low, meaning the antibiotic's target is largely inactive. Consequently, the antibiotic is rendered ineffective against this subpopulation, a form of phenotypic tolerance.\n\n3.  **Persister Cell Formation:** The observation of biphasic killing curves is the definitive hallmark of persister cells. The initial rapid decline in viable cells corresponds to the killing of the metabolically active, susceptible population. The subsequent plateau indicates the survival of a small, specialized subpopulation that is phenotypically tolerant. These persister cells are in a dormant, non-growing state, which makes them impervious to antibiotics that target active processes, even at concentrations well above the MIC. The fact that this fraction \"later repopulates once the antibiotic is removed\" confirms that this is a transient, non-heritable phenotype. Upon removal of the stress (the antibiotic), persisters can \"wake up\" and resume growth, leading to relapse of the infection.\n\n**Evaluation of Options:**\n\n**A. The EPS matrix reduces the effective diffusion coefficient $D_{\\text{eff}}$ relative to free solution and can sequester certain antibiotics, creating a spatial concentration profile $C(x)$ where deeper layers do not attain $C(x)\\ge\\text{MIC}$. Additionally, $\\beta$-lactamases produced by Klebsiella pneumoniae concentrated within the matrix locally degrade $\\beta$-lactams, steepening the decline of $C(x)$ with depth.**\nThis statement accurately describes the reaction-diffusion limitation mechanism. It correctly identifies the role of the EPS in reducing $D_{\\text{eff}}$ and the role of $\\beta$-lactamases in degrading the antibiotic. Both effects contribute to the observed steep concentration gradient, causing the concentration in deeper layers to be sub-inhibitory ($C(x) < \\text{MIC}$). This explanation is directly supported by the confocal imaging data and the known properties of biofilms and *K. pneumoniae*.\n**Verdict: Correct**\n\n**B. Nutrient and oxygen gradients drive interior cells into slow-growth or stationary states with low specific growth rate $\\mu\\approx 0$, reduced proton motive force, and downregulated target activity; antibiotics that require active processes (for example, $\\beta$-lactams for cell wall synthesis or aminoglycosides for energy-dependent uptake) are thus less effective in these zones.**\nThis statement accurately describes tolerance arising from metabolic heterogeneity. It correctly links the observed anoxic zone to the emergence of a slow-growing subpopulation and explains why a growth-dependent antibiotic like a $\\beta$-lactam would be ineffective against these cells. This mechanism is a cornerstone of biofilm antibiotic tolerance and is directly supported by the oxygen microelectrode data.\n**Verdict: Correct**\n\n**C. A subpopulation of persister cells enters a transient dormant phenotype without heritable genetic change. These cells survive high antibiotic exposure and repopulate once the drug is removed, explaining the biphasic killing curves and non-heritable tolerance observed in biofilms.**\nThis statement is the textbook definition of persister cells and their role in antibiotic tolerance. It provides a direct and precise explanation for the observed biphasic killing curve and the subsequent repopulation, which are key features of the problem statement. This is a well-established mechanism of tolerance, distinct from but often co-occurring with, the mechanisms in A and B.\n**Verdict: Correct**\n\n**D. Horizontal gene transfer within biofilms rapidly fixes chromosomal resistance mutations across the entire population during a single treatment course, making stable genetic resistance the primary cause of the observed tolerance in this scenario.**\nThis statement is flawed. While horizontal gene transfer (HGT) is a critical mechanism for the spread of resistance (e.g., ESBL-carrying plasmids), the acquisition and fixation of *new* resistance mutations across an *entire* population is an evolutionary process that occurs over many generations, not \"rapidly... during a single treatment course\". Furthermore, it posits stable genetic resistance as the *primary* cause, which contradicts the evidence for phenotypic tolerance (persisters that repopulate, slow-growers in anoxic zones). The phenomenon described is one of acute tolerance, not rapid evolution of the entire population to a new heritable state.\n**Verdict: Incorrect**\n\n**E. Uniform, high-level overexpression of efflux pumps by all biofilm cells fully accounts for the observed tolerance, rendering diffusion limitations, metabolic state changes, and persister formation unnecessary to explain the data.**\nThis statement is flawed on multiple grounds. First, it asserts \"uniform\" expression by \"all\" cells, which is contrary to the established principle and direct evidence (anoxic zone) of extreme heterogeneity within biofilms. Gene expression, including that of efflux pumps, is highly variable and depends on a cell's local microenvironment. Second, it claims this single mechanism \"fully accounts\" for tolerance and makes others \"unnecessary\". This is an oversimplification. Biofilm tolerance is quintessentially multifactorial, and the provided data (concentration gradients, anoxia, biphasic killing) are explicit evidence for the mechanisms described in options A, B, and C. A single mechanism cannot render these other, clearly observed phenomena unnecessary.\n**Verdict: Incorrect**\n\nIn summary, the observed antibiotic tolerance is a result of the combined, synergistic effects of diffusion-reaction limitation (A), metabolic stratification leading to phenotypic tolerance (B), and the presence of dormant persister cells (C).", "answer": "$$\\boxed{ABC}$$", "id": "4643195"}, {"introduction": "Understanding the biology of resistance is one thing; reliably detecting it in a clinical setting is another. This final practice bridges the gap between fundamental microbiology and diagnostic decision-making. You will apply Bayes' theorem, a powerful tool for reasoning under uncertainty, to interpret the results from two different diagnostic tests for a critical resistance gene. This exercise demonstrates how clinical microbiologists use probability to combine evidence and increase their confidence in a diagnosis, directly impacting patient care [@problem_id:4643188].", "problem": "A hospitalized immunocompromised patient develops ventilator-associated pneumonia, and a sputum isolate is identified as Klebsiella pneumoniae. In this healthcare setting, surveillance data indicate that the prior probability that a Klebsiella pneumoniae isolate from such infections carries the Klebsiella pneumoniae carbapenemase gene ($\\text{blaKPC}$) is $0.60$. A carbapenemase phenotypic assay is performed and returns a positive result. A gene-specific polymerase chain reaction (PCR) for $\\text{blaKPC}$ is then performed and also returns a positive result. Validation studies in this setting have established the following performance characteristics specifically for detecting $\\text{blaKPC}$ in Klebsiella pneumoniae isolates: the phenotypic assay has sensitivity $0.92$ and specificity $0.85$, and the PCR has sensitivity $0.98$ and specificity $0.99$. Assume that, conditional on the true $\\text{blaKPC}$ status, the phenotypic assay result and the PCR result are independent. Using Bayes’ theorem and the standard definitions of sensitivity and specificity, compute the posterior probability that $\\text{blaKPC}$ is present given both a positive phenotypic assay and a positive PCR result. Express your final answer as a decimal and round to four significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n**Step 1: Extract Givens**\n- Prior probability of the isolate carrying the $\\text{blaKPC}$ gene: $P(\\text{KPC}) = 0.60$.\n- Test 1: Carbapenemase phenotypic assay, result is positive.\n- Test 2: Gene-specific polymerase chain reaction (PCR), result is positive.\n- Phenotypic assay sensitivity: $0.92$.\n- Phenotypic assay specificity: $0.85$.\n- PCR sensitivity: $0.98$.\n- PCR specificity: $0.99$.\n- Assumption: The phenotypic assay result and the PCR result are independent, conditional on the true $\\text{blaKPC}$ status.\n- Objective: Compute the posterior probability that $\\text{blaKPC}$ is present given both positive test results.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is a classic application of Bayes' theorem in the context of medical diagnostics. The scenario is scientifically realistic: *Klebsiella pneumoniae* carbapenemase ($\\text{KPC}$) is a significant mechanism of antibiotic resistance, and PCR and phenotypic assays are standard methods for its detection. The provided sensitivity and specificity values are plausible. The problem is self-contained, providing all necessary probabilities and a clear conditional independence assumption. The question is unambiguous and asks for a specific, calculable quantity. There are no contradictions, factual errors, or subjective elements.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. A solution will be derived.\n\nLet $K$ be the event that the *Klebsiella pneumoniae* isolate carries the $\\text{blaKPC}$ gene.\nLet $K^c$ be the complement event, that the isolate does not carry the $\\text{blaKPC}$ gene.\nLet $T_P^+$ be the event of a positive phenotypic assay result.\nLet $T_{PCR}^+$ be the event of a positive PCR result.\n\nThe problem provides the following probabilities:\nThe prior probability of the gene being present is $P(K) = 0.60$.\nThe prior probability of the gene being absent is $P(K^c) = 1 - P(K) = 1 - 0.60 = 0.40$.\n\nThe performance characteristics of the tests are given as sensitivities and specificities:\nFor the phenotypic assay:\nSensitivity: $P(T_P^+ | K) = 0.92$.\nSpecificity: $P(T_P^- | K^c) = 0.85$.\nFrom the specificity, we can derive the false positive rate for the phenotypic assay:\n$P(T_P^+ | K^c) = 1 - P(T_P^- | K^c) = 1 - 0.85 = 0.15$.\n\nFor the PCR assay:\nSensitivity: $P(T_{PCR}^+ | K) = 0.98$.\nSpecificity: $P(T_{PCR}^- | K^c) = 0.99$.\nFrom the specificity, we can derive the false positive rate for the PCR assay:\n$P(T_{PCR}^+ | K^c) = 1 - P(T_{PCR}^- | K^c) = 1 - 0.99 = 0.01$.\n\nThe objective is to compute the posterior probability of the gene being present given that both tests are positive, which is denoted as $P(K | T_P^+ \\cap T_{PCR}^+)$. For brevity, we denote the joint event of two positive tests as $E = T_P^+ \\cap T_{PCR}^+$. We wish to find $P(K|E)$.\n\nUsing Bayes' theorem:\n$$ P(K|E) = \\frac{P(E|K)P(K)}{P(E)} $$\nThe denominator, $P(E)$, can be expanded using the law of total probability:\n$$ P(E) = P(E|K)P(K) + P(E|K^c)P(K^c) $$\nSubstituting this into the Bayes' formula gives:\n$$ P(K|E) = \\frac{P(E|K)P(K)}{P(E|K)P(K) + P(E|K^c)P(K^c)} $$\nThe problem states that the test results are conditionally independent. This means that given the true status of the gene (present or absent), the probability of one test result does not depend on the other.\nMathematically, this conditional independence is expressed as:\n$P(T_P^+ \\cap T_{PCR}^+ | K) = P(T_P^+|K)P(T_{PCR}^+|K)$\nAnd,\n$P(T_P^+ \\cap T_{PCR}^+ | K^c) = P(T_P^+|K^c)P(T_{PCR}^+|K^c)$\n\nWe can now calculate the terms $P(E|K)$ and $P(E|K^c)$:\n$P(E|K) = P(T_P^+|K)P(T_{PCR}^+|K) = (0.92)(0.98) = 0.9016$.\n$P(E|K^c) = P(T_P^+|K^c)P(T_{PCR}^+|K^c) = (0.15)(0.01) = 0.0015$.\n\nNow we can compute the numerator and denominator of the Bayesian formula.\nThe numerator is:\n$P(E|K)P(K) = (0.9016)(0.60) = 0.54096$.\n\nThe denominator is:\n$P(E) = P(E|K)P(K) + P(E|K^c)P(K^c)$\n$P(E) = (0.9016)(0.60) + (0.0015)(0.40)$\n$P(E) = 0.54096 + 0.0006 = 0.54156$.\n\nFinally, we compute the posterior probability:\n$$ P(K|E) = \\frac{0.54096}{0.54156} \\approx 0.99889246 $$\nThe problem requires the answer to be rounded to four significant figures.\n$$ P(K | T_P^+ \\cap T_{PCR}^+) \\approx 0.9989 $$\nThis result indicates that given the high prior probability and two positive test results, especially the highly specific PCR, it is extremely probable that the isolate possesses the $\\text{blaKPC}$ gene.", "answer": "$$\n\\boxed{0.9989}\n$$", "id": "4643188"}]}